Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00511264
Status:
COMPLETED
Last Update Posted:
2008-05-29
First Post:
2007-08-01
Brief Title:
Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal Tract
Sponsor:
Odense University Hospital
Organization:
Odense University Hospital
Study Overview
Official Title:
Prospective Evaluation of the Impact of Laparoscopic Ultrasound LUS Guided Fine-Needle Aspiration or Tru-Cut Biopsy in Patients With Upper GI Tract Cancer
Status:
COMPLETED
Status Verified Date:
2008-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Laparoscopic Ultrasound LUS is an important part of the pre-treatment evaluation of patients with upper gastrointestinal tract cancer esophageal gastric pancreatic and liver cancer When a suspect lesion is visualized during LUS a biopsy should be provided in order to differentiate between benign and malignant lesions A new system for LUS guided biopsy has been developed but how often these biopsies are clinically relevant ie changing patient managementand how reliable are these biopsies are unknown
The study hypothesis is that LUS guided biopsies are accurate and clinically relevant in the pre-treatment evaluation of patients with upper gastrointestinal tract cancer
The study hypothesis is that LUS guided biopsies are accurate and clinically relevant in the pre-treatment evaluation of patients with upper gastrointestinal tract cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None